Runaway inflation and economic instability is terrible for just about everybody, but are efforts to tackle this problem creating more?
To answer that, Kirsten Axelsen, Senior Policy Advisor at DLA Piper, joins the show to break down all the effects The Inflation Reduction act is having upon medicine,
We discuss:

• The potential negative impacts on small-molecule medicine
• How the act affects patents and generic medicine
• Why we may see declines in small-molecule medicine research